Phase II Study , Association of Cisplatine Topotecan and Cetuximab in Patients Whith Late or in Progress Epithelial Cancer of the Cervix

Inclusion Criteria: * More than 18 years old. * Epidermoïde carcinoma or adenocarcinoma of the cervix, hystologic proved * Patientes in a late stage or with progresive desease. * One mesurable lesion in irradiated zone. * Patient who have already treated radio-chimiothérapy with platine should have a 6 month free interval. * Index status of ECOG (" Eastern Cooperative Oncology Group ")less than 2. * Good biologicals and hematologicals fonctions: * Neutrophiles noless than 1,5.109/L. * Platelets nolss than 100.109/L. * Total bilirubin no more than 1,5 time the normal superior range. * Transaminases no mote than 3 x Time NSR * Creatinine clairance Cockroft) more than 50 mL/min . * Inform consent signed. Exclusion Criteria: * Previous cytotoxic traitement exept radio-chaemiotherapy of the pelvis cerebrals metastasis. * Other cancer in the last 5 years exept treated BCC. * Dermatologic desease. * Crohn desease or Hemorragic rectal-Colitis. * Neuropathy. * Psychologic disorder. * Social troubles. * Pregnant women.